Redx Pharma Plc Market Competitor 2016 Forecast to 2022

The report provides comprehensive information on the therapeutics under development by Redx Pharma Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/619232-redx-pharma-plc-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Redx Pharma Plc

- The report provides overview of Redx Pharma Plc including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Redx Pharma Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Redx Pharma Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Redx Pharma Plc’s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Redx Pharma Plc

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Redx Pharma Plc’s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Redx Pharma Plc Snapshot 5

Redx Pharma Plc Overview 5

Key Information 5

Key Facts 5

Redx Pharma Plc - Research and Development Overview 6

Key Therapeutic Areas 6

Redx Pharma Plc - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Redx Pharma Plc - Pipeline Products Glance 13

Redx Pharma Plc - Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Redx Pharma Plc - Drug Profiles 15

RDX-001 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

RDX-002 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

RDX-003 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

RDX-004 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecules to Inhibit cFMS Kinase for Immunology and Oncology 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecules to Inhibit DNA Gyrase for Neisseria Gonorrhoeae Infections 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecules for Bacterial Infections 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecules for Hepatitis B 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Small Molecules for Oncology 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Small Molecules to Inhibit IDO for Solid Tumors 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecules to Inhibit Neuraminidase for Influenza A and B Infections 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Small Molecules to Inhibit Pan-Raf Kinases for Colorectal Cancer 26

Product Description 26

Mechanism of Action 26

                                                      

Access Report @ https://www.wiseguyreports.com/reports/619232-redx-pharma-plc-product-pipeline-review-2016

Contact Info:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)                                                   

Get in touch:

LinkedIn: www.linkedin.com/company/4828928

Twitter: https://twitter.com/WiseGuyReports

Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts